Message from the Convenors
The 25th AGITG ASM will be held in Aotearoa New Zealand for the first time. We are delighted to be welcoming you to Te Pae The Christchurch Convention Centre.
The theme of this year’s meeting is Navigating Paths to Equity in GI Cancer Research, stemming from the pressing need to extend access and increase equity to therapeutic options across regional, rural and remote (RRR) areas, as well as culturally diverse and First Nations population.
Since 1991, the AGITG has been the only research organisation in the Australasian region with a focus on all gastro-intestinal cancers. The ASM is a major highlight of the year, providing an opportunity for increased involvement in the scientific activities of the AGITG and encouraging subsequent ongoing participation in the group’s research. This year’s ASM will be no different and will encourage collaboration between members across Australia and New Zealand.
The four day meeting will provide extensive engagement opportunities for members and sponsors. Day one offers several dedicated workshops, followed by an insightful and collaborative three day program featuring international and local invited faculty, symposia and trial presentations.
We look forward to you joining us in Christchurch at our 25th ASM!
Dr Ben Lawrence and Prof Stephen Ackland
AGITG Annual Scientific Meeting Co-Convenors
Testimonials
Dr Dmitri Shek
Western Sydney Local Health District and Western Sydney University

Dr Dmitri Shek
Western Sydney Local Health District and Western Sydney University, NSW Australia
The AGITG ASM 2022 was a unique opportunity to reconnect with friends and colleagues across the APAC. Due to Covid-19 pandemic this was the first face-to-face conference for me in the last three years. Presenting a poster and receiving a feedback from the experts in the field of GI oncology is extremely helpful for the future career development. I especially enjoyed sessions about New Concepts and Breakout Sessions on mCRC. It was great to listen/see presentations by prominent scientists like Chris Karapetis and to get familiar with current major hurdles in GI oncology. Finally, the Gala Dinner was brilliantly organised and the food was awesome. Thank you AGITG for the great conference and I am looking forward to the next ASM in New Zealand.
Dr Natalie Collier
Liverpool Cancer Therapy Centre, NSW Australia

Dr Natalie Collier
Liverpool Cancer Therapy Centre, NSW Australia
I attended my first AGITG ASM in 2020, which was condensed into a one-day virtual meeting. Despite the change in format, the passion and collegiality of AGITG just flowed through the online platform. It was both impressive and educational to hear of AGITG trial updates and successes, particularly during these current challenging times. I presented at the New Concepts Symposium and was honoured to receive the runner-up award, along with extremely valuable feedback which will help to shape and progress my trial concept. I look forward to joining many more ASMs in the future, and would highly recommend it, especially to those early on in their research career for encouragement and inspiration.
A/Prof Manisha Palta
Duke University School of Medicine, USA

A/Prof Manisha Palta
Duke University School of Medicine, USA
The AGITG Annual Scientific Meeting was nothing sort of exceptional. There is true multi-disciplinary integration with medical oncologists, radiation oncologists, surgeons, and the clinical trial portfolio of the AGITG is impressive. Attending this meeting was an excellent experience and I look forward to future opportunities to attend.
Prof Stephen J Wigmore
Royal Infirmary of Edinburgh, The United Kingdom

Prof Stephen J Wigmore
Regius Professor of Cinical Surgery
University of Edinburgh
The AGITG Annual Scientific Meeting was a really welcoming environment to discuss advances in treatment of GI cancers. I very much liked the interdisciplinary approach with oncologists, radiation oncologists, surgeon clinical nurse specialists, allied health and client groups all well represented. This meant that there was holistic approach to most discussions. The trial portfolio that the members of AGITG have put together was very impressive and well structured and I liked that the members clearly felt invested in the delivery of good quality trials. The international and local speakers were all excellent and the social programme was very entertaining. All in all a great experience that I look forward to repeating!
Naomi Knoblauch
Hunter Medical Research Institute

Naomi Knoblauch
Hunter Medical Research Institute
Newcastle, NSW
This was my second AGITG ASM and I was not disappointed. The quality and relevance of the Study Coordinator sessions was exceptional and provided an excellent opportunity to discuss the unique challenges of trial conduct at sites. I was thrilled also to accept the Outstanding Site ward on behalf of my colleagues in the Medical Oncology Clinical Trials Unit at Calvary Mater Newcastle. The recognition of the contribution of individual trial sites is a wonderful initiative and I encourage all to apply.
Sally Dean
Newcastle Private Hospital, NSW Australia

Sally Dean
Clinical Trial Coordinator
Newcastle Private Hospital
Australia
“I attended the AGITG Annual Scientific Meeting in 2019 for the first time, and found the meeting provided an excellent opportunity to network, especially with other study coordinators. The meeting was well organised, while the program contained engaging and highly informative sessions. I thoroughly enjoyed the AGITG ASM, finding it interesting and highly relevant for study coordinators. I look forward to attending many more meetings.”
Dr Mark McGregor
Queen Elizabeth Hospital, South Australia

Dr Mark McGregor
Clinical Research Fellow
Medical Oncology
Queen Elizabeth Hospital
South Australia
“This was my first AGITG meeting and I found it to be a great experience. There was a wide range of topics and expert speakers across surgical and oncological specialties with excellent interactive sessions. The New Concepts Symposium was a great opportunity to present clinical trial proposals and receive real-time feedback, with a clear pathway for further collaboration and development of protocols to get trial ideas off the ground. I will definitely be back for future meetings.”
Prof Christian Jobin
University of Florida, Gainesville

Prof Christian Jobin
Gatorade Trust Professor of Medicine
Program Co-leader Cancer Therapeutics and Host Response
University of Florida, Department of Medicine
Division of Gastroenterology
Program Co-leader Cancer Therapeutics and Host Response
University of Florida, Department of Medicine
Division of Gastroenterology
“It was my first experience at the AGITG Annual Scientific Meeting and although I typically do not attend clinical meetings, I was impressed by the quality of this meeting, both with content and expertise of attendees and faculties. The level of participation from attendees during the “question-answer” period was outstanding and made the meeting very interactive. I had numerous and fruitful interaction with attendees and faculties not only during breaks and hallway encounter but during dinners and receptions. In summary, I was “sold” on this meeting because of both high quality content, expertise of participants and high level of interaction. I highly recommend it.”
Prof Andrew Barbour
Princess Alexandra Hospital, Brisbane

Prof Andrew Barbour
Surgeon
Princess Alexandra Hospital, Brisbane
Princess Alexandra Hospital, Brisbane
“The AGITG ASM is a multidisciplinary meeting focussed on the current and future management of GI cancer. It provides not only high quality educational material across the spectrum of GI cancer, but encourages the presentation of new clinical trial ideas. Through the New Concepts Symposium, clinical trial concepts are presented and refined for development into national or international studies. The meeting is suitable for trainees and senior clinicians as well as paramedical practitioners engaged in all aspects of GI cancer management.”
Dr Sharon Pattison
University of Otago and Southern District Health Board, Dunedin

Dr Sharon Pattison
Medical Oncologist
University of Otago and Southern District Health Board, Dunedin
University of Otago and Southern District Health Board, Dunedin
“I attended my first AGITG Annual Scientific Meeting as an advanced trainee newly starting a PhD. It was a great educational meeting that had instructive symposia with an interesting and approachable local and international faculty. Those features have been present at each AGITG ASM that I have subsequently attended, and I have found the ASM to be an invaluable forum for presentation of research, less formal discussion of research themes and ideas, and learning about the challenges involved in clinical trial design. The AGITG ASM environment supports collaboration and networking, and I would highly recommend the meeting to all trainees, researchers, investigators and clinicians who have an interest in gastro-intestinal cancers.”
Ms Anne Smith
Canterbury Regional Cancer and Haematology Service

Ms Anne Smith
Clinical Trials Manager
Christchurch Oncology Research Unit
Canterbury Regional Cancer and Haematology Service
Christchurch Oncology Research Unit
Canterbury Regional Cancer and Haematology Service
“Key to the AGITG philosophy is a desire to improve the health and quality of life of people with gastro-intestinal cancer by conducting high quality collaborative clinical trials. In developing and conducting these trials the AGITG has successfully encompassed specialists, nurses, research coordinators, scientists, allied health professionals and consumers.
The AGITG Annual Scientific Meeting provides an excellent forum for all these disciplines to come together to share knowledge and experiences and learn from a wide variety of invited international speakers. Incorporated in the meeting are sessions specifically targeting study coordinators and allied health professionals. Speakers and topics for interactive discussion are chosen to complement the annual theme of the meeting and address issues that may arise from a study coordinator perspective.
This is a valuable meeting and excellent opportunity to learn more about clinical trials, changes in medical practice and to exchange ideas and experiences with other study coordinators.”
Dr David Lau
Olivia Newton John Cancer Research Centre

Dr David Lau
Clinical Research Fellow
Olivia Newton John Cancer Research Centre
Recipient of the 2018 Merck-AGITG Clinical Research Fellowship
Olivia Newton John Cancer Research Centre
“The AGITG Annual Scientific Meeting is a thoroughly enjoyable conference for all involved in GI cancer. The AGITG have a longstanding commitment to education and invite a high calibre of international and local speakers to deliver an informative program. As an early-career delegate, the conference provided me with a forum to present my research and meet likeminded clinicians, researchers and new collaborators.”